Literature DB >> 27697812

The epidemiology of polypharmacy.

Rupert A Payne1.   

Abstract

Polypharmacy describes, in simplistic terms, the use of multiple medications in an individual. It has become a normal aspect of modern medicine, driven by an ageing, multimorbid population, the increasing availability of preventative medications and an increasing use of single-disease guidelines and adherence to evidence-based practice. However, polypharmacy is also associated with a range of adverse outcomes, and is considered an important and increasing challenge for clinical practice. Here, we consider the definitions of polypharmacy, the extent and nature of medication use in different settings, and the type of problems encountered as a consequence of polypharmacy. © Royal College of Physicians 2016. All rights reserved.

Keywords:  Multimorbidity; pharmacoepidemiology; potentially inappropriate prescribing; ­polypharmacy

Mesh:

Year:  2016        PMID: 27697812      PMCID: PMC6297306          DOI: 10.7861/clinmedicine.16-5-465

Source DB:  PubMed          Journal:  Clin Med (Lond)        ISSN: 1470-2118            Impact factor:   2.659


  26 in total

1.  Using the NO TEARS tool for medication review.

Authors:  Tessa Lewis
Journal:  BMJ       Date:  2004-08-21

2.  A method for assessing drug therapy appropriateness.

Authors:  J T Hanlon; K E Schmader; G P Samsa; M Weinberger; K M Uttech; I K Lewis; H J Cohen; J R Feussner
Journal:  J Clin Epidemiol       Date:  1992-10       Impact factor: 6.437

3.  Polypharmacy as commonly defined is an indicator of limited value in the assessment of drug-related problems.

Authors:  Kirsten K Viktil; Hege S Blix; Tron A Moger; Aasmund Reikvam
Journal:  Br J Clin Pharmacol       Date:  2006-08-30       Impact factor: 4.335

Review 4.  A systematic review of barriers to medication adherence in the elderly: looking beyond cost and regimen complexity.

Authors:  Walid F Gellad; Jerry L Grenard; Zachary A Marcum
Journal:  Am J Geriatr Pharmacother       Date:  2011-02

5.  Prevalence of potentially inappropriate prescribing in an acutely ill population of older patients admitted to six European hospitals.

Authors:  Paul Gallagher; Pierre Olivier Lang; Antonio Cherubini; Eva Topinková; Alfonso Cruz-Jentoft; Beatriz Montero Errasquín; Pavla Mádlová; Beatrice Gasperini; Hilde Baeyens; Jean-Pierre Baeyens; Jean-Pierre Michel; Denis O'Mahony
Journal:  Eur J Clin Pharmacol       Date:  2011-05-17       Impact factor: 2.953

6.  Increasing polypharmacy - an individual-based study of the Swedish population 2005-2008.

Authors:  Bo Hovstadius; Karl Hovstadius; Bengt Astrand; Göran Petersson
Journal:  BMC Clin Pharmacol       Date:  2010-12-02

7.  Adverse drug reactions as cause of admission to hospital: prospective analysis of 18 820 patients.

Authors:  Munir Pirmohamed; Sally James; Shaun Meakin; Chris Green; Andrew K Scott; Thomas J Walley; Keith Farrar; B Kevin Park; Alasdair M Breckenridge
Journal:  BMJ       Date:  2004-07-03

8.  Polypharmacy and its correlates in village health clinics across 10 provinces of Western China.

Authors:  Lifang Dong; Hong Yan; Duolao Wang
Journal:  J Epidemiol Community Health       Date:  2009-10-23       Impact factor: 3.710

9.  Impact of the NICE guideline recommending cessation of antibiotic prophylaxis for prevention of infective endocarditis: before and after study.

Authors:  Martin H Thornhill; Mark J Dayer; Jamie M Forde; G Ralph Corey; Vivian H Chu; David J Couper; Peter B Lockhart
Journal:  BMJ       Date:  2011-05-03

10.  Adverse drug reactions in hospital in-patients: a prospective analysis of 3695 patient-episodes.

Authors:  Emma C Davies; Christopher F Green; Stephen Taylor; Paula R Williamson; David R Mottram; Munir Pirmohamed
Journal:  PLoS One       Date:  2009-02-11       Impact factor: 3.240

View more
  44 in total

1.  Comparison of the Pharmacokinetic Profiles of Ceftriaxone Used Alone and Combined with Danhong Injection in Old Rats.

Authors:  Qian Zhang; Jianming Guo; Guoliang Dai; Jianping Li; Lijing Zhu; Shufen He; Yang Zong; Zhishu Tang; Buchang Zhao; Wenzheng Ju; Jinao Duan
Journal:  Eur J Drug Metab Pharmacokinet       Date:  2019-08       Impact factor: 2.441

Review 2.  Novel thyroxine formulations: a further step toward precision medicine.

Authors:  Camilla Virili; Pierpaolo Trimboli; Marco Centanni
Journal:  Endocrine       Date:  2019-10-15       Impact factor: 3.633

3.  Drug-physiology interaction and its influence on the QT prolongation-mechanistic modeling study.

Authors:  Barbara Wiśniowska; Sebastian Polak
Journal:  J Pharmacokinet Pharmacodyn       Date:  2018-03-15       Impact factor: 2.745

4.  Medical-encounter mental health diagnoses, non-fatal injury and polypharmacy indicators of risk for accident death in the US Army enlisted soldiers, 2004-2009.

Authors:  Lisa Lewandowski-Romps; Heather M Schroeder; Patricia A Berglund; Lisa J Colpe; Kenneth Cox; Keith Hauret; Jeffrey D Hay; Bruce Jones; Roderick J A Little; Colter Mitchell; Michael Schoenbaum; Paul Schulz; Murray B Stein; Robert J Ursano; Steven G Heeringa
Journal:  Prev Med       Date:  2017-11-17       Impact factor: 4.018

5.  Polypharmacy and emergency readmission to hospital after critical illness: a population-level cohort study.

Authors:  Angus J Turnbull; Eddie Donaghy; Lisa Salisbury; Pamela Ramsay; Janice Rattray; Timothy Walsh; Nazir Lone
Journal:  Br J Anaesth       Date:  2020-10-31       Impact factor: 9.166

6.  Drug-drug interaction database for safe prescribing of systemic antifungal agents.

Authors:  Saarah Niazi-Ali; Graham T Atherton; Marcin Walczak; David W Denning
Journal:  Ther Adv Infect Dis       Date:  2021-04-30

7.  Prevalence and predictors of potentially inappropriate prescribing in middle-aged adults: a repeated cross-sectional study.

Authors:  Amandeep Khatter; Frank Moriarty; Mark Ashworth; Stevo Durbaba; Patrick Redmond
Journal:  Br J Gen Pract       Date:  2021-06-24       Impact factor: 6.302

8.  Pharmacological Predictors of Morbidity and Mortality in COVID-19.

Authors:  Christopher Oddy; James McCaul; Polly Keeling; Jonathan Allington; Dhanuja Senn; Neesha Soni; Hannah Morrison; Ruwani Mawella; Thomas Samuel; John Dixon
Journal:  J Clin Pharmacol       Date:  2021-08-01       Impact factor: 2.860

9.  Holmium laser enucleation of the prostate: efficacy, safety and preoperative management in patients presenting with anticoagulation therapy.

Authors:  Marina Deuker; Jessica Rührup; Pierre I Karakiewicz; Maria Welte; Luis A Kluth; Severine Banek; Frederik C Roos; Philipp Mandel; Felix K-H Chun; Andreas Becker
Journal:  World J Urol       Date:  2020-06-02       Impact factor: 4.226

10.  The health impacts of preventive cardiovascular medication reduction on older populations: protocol for a systematic review and meta-analysis.

Authors:  Rik S van der Veen; Joseph J Lee; Richard J McManus; Richard F D Hobbs; Kamal R Mahtani; Constantinos Koshiaris; James P Sheppard
Journal:  Syst Rev       Date:  2021-06-24
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.